neurodegenerative diseases
Do Microbes Trigger Alzheimer’s Disease?
Do Microbes Trigger Alzheimer’s Disease?
Jill U. Adams | Sep 1, 2017
The once fringe idea is gaining traction among the scientific community.
Infographic: Brain Infection and Alzheimer’s Disease Pathology
Infographic: Brain Infection and Alzheimer’s Disease Pathology
Jill U. Adams | Aug 31, 2017
Emerging evidence links bacterial or viral infection with the neuropathology of Alzheimer’s disease.
Parkinson’s Disease Cell Therapy Relieves Symptoms in Monkeys
Parkinson’s Disease Cell Therapy Relieves Symptoms in Monkeys
Abby Olena | Aug 30, 2017
Neurons derived from human induced pluripotent stem cells fill in for lost dopamine neurons in a primate model of the disease.
A Potential Remedy for the Aging Brain
A Potential Remedy for the Aging Brain
Aggie Mika | Aug 8, 2017
In mice, injected fragments of a naturally occurring protein boost memory in young and old animals and improve cognition and mobility in a model of neurodegenerative disease. 
Second-Ever ALS Drug Approved
Second-Ever ALS Drug Approved
Jef Akst | May 8, 2017
Amyotrophic lateral sclerosis patients in the U.S. now have an option besides riluzole, which was approved by the FDA more than two decades ago and only extends life by two or three months.
Opinion: Canine Models for Alzheimer’s
Opinion: Canine Models for Alzheimer’s
Edward G. Barrett | Mar 1, 2017
For research on drugs to treat neurodegenerative diseases, dogs offer a better predictor of clinical outcomes. 
FDA Approves First Treatment for Spinal Muscular Atrophy
FDA Approves First Treatment for Spinal Muscular Atrophy
Ben Andrew Henry | Dec 28, 2016
The oligonucleotide therapeutic will soon be available in the U.S.
Gut Microbes Linked to Neurodegenerative Disease
Gut Microbes Linked to Neurodegenerative Disease
Abby Olena | Dec 1, 2016
Bacteria in the intestine influence motor dysfunction and neuroinflammation in a mouse model of Parkinson’s disease.
New Support for Experimental Alzheimer’s Drug
New Support for Experimental Alzheimer’s Drug
Jef Akst | Nov 2, 2016
Merck’s verubecestat, which is currently being tested in two Phase 3 studies, is safe, according to newly published Phase 1 data.
Influential Alzheimer’s Researcher Dies
Influential Alzheimer’s Researcher Dies
Jef Akst | Oct 6, 2016
Allen Roses, a professor of neurobiology at Duke University School of Medicine, has passed away at age 73.